drugset / Trial / NCT01376232

Study to Assess the Pharmacokinetics of GSK1278863A Coadministered With a High Fat Meal or an Inhibitor of CYP2C8 (Gemfibrozil)

NCT01376232

RandomizedSingle-groupOpen-labelOther

Summary

Study to Assess the Pharmacokinetics of GSK1278863A Coadministered with a High Fat Meal or an Inhibitor of CYP2C8 (gemfibrozil),\]

Timeline

Start
2010-11-08
Primary completion
2010-12-20
Completion
2010-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Daprodustat Small molecule 100 mg Oral
Subject Gemfibrozil Small molecule 600 mg Oral

Indications